Full Text View
Tabular View
No Study Results Posted
Related Studies
Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo
This study has been completed.
Study NCT00334048   Information provided by St. Luke's-Roosevelt Hospital Center
First Received: June 2, 2006   Last Updated: October 15, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sexual Dysfunction
Interventions listed in this trial
Ropinirole (Requip)
Additional drug interventions recognized in this trial
Antidepressive Agents
Ropinirole
Serotonin Uptake Inhibitors
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Dopamine Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Therapeutic Uses
Sponsors listed in this trial
St. Luke's-Roosevelt Hospital Center
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services